GENERATIVE BIOLOGICS
LIVE

Serial Number

98387645

Owner

Insilico Medicine IP Limited

Attorney

Jacqueline M. Lesser

Filing Date

Feb 1, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GENERATIVE BIOLOGICS Trademark

Serial Number: 98387645

GENERATIVE BIOLOGICS is a trademark filed by Insilico Medicine IP Limited on February 1, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Insilico Medicine IP Limited (20 trademarks)

Three Exchange Square, 8 Connaught Place
Central , HK

Entity Type: 77

Trademark Details

Filing Date

February 1, 2024

Registration Date

Not Registered

Published for Opposition

December 3, 2024

Goods & Services

Technological research relating to patent mapping; scientific research and development; scientific and technical research relating to patent mapping; research in the field of artificial intelligence; research and development of new products; scientific laboratory services, namely laboratory services in biologics design and development; cancer research for medical purposes; artificial intelligence consultancy in biologics design and development, namely, chemistry services, clinical trials, biomedical research services, medical laboratory service, medical research service; design and development of computer software; design and development of computer software, namely developing customized software in the field of biologics design and development, including peptides, nanobodies, and antibodies tailored for specific targets; computer software installation, maintenance and repair and updating of computer software; installation of software using artificial intelligence for automated machine learning in the field of biologics design and development, including peptides, nanobodies, and antibodies tailored for specific targets; development of computer platforms; research in computer natural language processing; design of computer-simulated models; software as a service (SAAS) services featuring software for using artificial intelligence for automated machine learning in the field of biologics design and development, including peptides, nanobodies, and antibodies tailored for specific targets; software development in the framework of software publishing; platform as a service (PAAS) featuring computer software platforms for using artificial intelligence for automated machine learning in the field of biologics design and development, including peptides, nanobodies, and antibodies tailored for specific targets; development of computer platforms; computer system design; rental of computer software; creating and designing website based indexes of data and information for others using information technology; computer programming services; maintenance of computer software; installation of computer software; installation, maintenance, and updating of computer software

Downloadable and recorded computer software; recorded or downloadable computer software platforms using artificial intelligence for automated machine learning in the field of biologics design and development; computer operating programs, recorded; data processing apparatus

Filing History

ASSIGNED TO EXAMINER
Apr 25, 2025 DOCK
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Apr 4, 2025 ETOP
OPPOSITION INSTITUTED NO. 999999
Apr 2, 2025 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 17, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 7, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 24, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 24, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 16, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 16, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 16, 2024 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 28, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 28, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2024 NWOS
NEW APPLICATION ENTERED
Feb 5, 2024 NWAP